Validation of endothelin-1 as a predictor of adverse prognosis in coronary artery disease patients with impaired kidney function with or without diabetes

Back

ESC Professional Premium Access

Validation of endothelin-1 as a predictor of adverse prognosis in coronary artery disease patients with impaired kidney function with or without diabetes

Session: Diabetes and coronary artery disease

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr Z. Ye (Beijing, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Zixiang Ye

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

0 follower

6 more presentations in this session

Differential effects of glucose-lowering agents on atherosclerotic plaque progression in diabetic patients: a retrospective cohort study using serial coronary CT angiography

Speaker: Doctor J. Zhang (Chengdu, CN)

Participant-level pericoronary adipose tissue attenuation predicts changes in plaque composition: a 1-year prospective study in asymptomatic individuals with type 2 diabetes mellitus

Speaker: Doctor K. Overgaard (Svendborg, DK)

Glycemic control and renal function decline in patients with chronic coronary syndrome

Speaker: Doctor C. HUANG (Taipei, TW)

Impact of prediabetes on long-term outcomes after percutaneous coronary interventions

Speaker: Doctor E. Steinacher (Vienna, AT)

Diabetes status and grade of left ventricular ejection fraction as predictors of outcomes in patients with Non-ST-segment elevation myocardial infarction

Speaker: Professor Y. Kim (Chuncheon, KR)

Access the full session

Diabetes and coronary artery disease

Speakers: Mr Z. Ye, Doctor J. Zhang, Doctor K. Overgaard, Doctor C. HUANG, Doctor E. Steinacher...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources